Accessing radiation response using hypoxia PET imaging and oxygen sensitive electrodes: a preclinical study

Area of Science:

• Oncology
• Radiotherapy
• Medical Imaging

Background:

• Tumor hypoxia is a significant challenge in radiotherapy, often leading to treatment resistance.
• Accurate assessment of tumor oxygenation is crucial for predicting treatment outcomes.

Purpose of the Study:

• To evaluate the prognostic value of tumor hypoxia using (18)F-fluoroazomycin arabinoside ((18)F-FAZA) PET and the Eppendorf oxygen electrode.
• To correlate hypoxia measurements with radiotherapy response in a preclinical tumor model.

Main Methods:

• 92 female CDF1 mice with subcutaneous C3H mammary carcinomas underwent pretreatment (18)F-FAZA PET scans.
• Oxygenation status of 80 tumors was assessed using an invasive Eppendorf oxygen electrode.
• Tumors were irradiated with a single dose of 55 Gy, and local tumor control was monitored for 90 days.

Main Results:

• A significant difference in local tumor control was observed between more and less hypoxic tumors, regardless of the measurement method.
• (18)F-FAZA PET identified significantly lower tumor control in more hypoxic tumors (P=0.007, HR=0.21).
• Eppendorf electrode measurements also showed significantly lower tumor control in more hypoxic tumors (P=0.018, HR=0.31).

Conclusions:

• Pretreatment tumor hypoxia, assessed by (18)F-FAZA PET, is a significant prognostic indicator of radiotherapy response.
• The Eppendorf pO(2) Histograph yielded similar prognostic results for tumor oxygenation.
• (18)F-FAZA PET shows promise as a non-invasive prognostic marker for tumor hypoxia and predicting radiation response.